![]() Use echocardiography to ensure that the device does not impinge on the free atrial wall or aortic root. ![]() Prior to device detachment, evaluate the position of the device relative to the free atrial wall and the aortic root using echocardiography.Transient hemodynamic compromise may be encountered during device placement, which may require fluid replacement or other medications as determined by the physician.Some patients may also develop an allergy to nickel if this device is implanted. Certain allergic reactions can be serious patients should be instructed to notify their physicians immediately if they suspect they are experiencing an allergic reaction such as difficulty breathing or inflammation of the face or throat. Patients who are allergic to nickel may have an allergic reaction to this device, especially those with a history of metal allergies. However, in vitro testing has demonstrated that nickel is released from this device for a minimum of 60 days. The Amplatzer™ Talisman™ PFO Occluder device consists of a nickel-titanium alloy, which is generally considered safe.Do not remove an embolized occluder through intracardiac structures unless the occluder is fully recaptured inside a catheter or sheath. Embolized devices must be removed as they may disrupt critical cardiac functions.This includes availability of a surgeon and access to operating room. Prepare for situations that require percutaneous or surgical removal of this device. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |